You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

P.vera

Showing 1 - 25 of 609
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Not yet recruiting
  • Polycythemia Vera (PV)
  • Mie, Japan
  • +5 more
Aug 15, 2023

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

Polycythemia Vera Trial in Italy

Recruiting
  • Polycythemia Vera
    • Reggio Calabria, Calabria, Italy
    • +21 more
    Nov 10, 2023

    Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

    Active, not recruiting
    • Polycythemia Vera
    • Ropeginterferon alfa-2b
    • Beijing, China
    • +13 more
    Aug 1, 2022

    Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

    Completed
    • Polycythemia Vera (PV)
    • Toon-shi, Ehime, Japan
    • +7 more
    Dec 8, 2021

    Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

    Completed
    • Adherence, Patient
    • Adherence, Treatment
      • Cosenza, Calabria, Italy
      • +27 more
      Oct 11, 2023

      Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

      Active, not recruiting
      • Polycythemia Vera
      • San Giovanni Rotondo, (FG) Puglia, Italy
      • +22 more
      Jan 10, 2023

      Duchenne and Becker Muscular Dystrophy, Polycytemia Vera Trial in Québec (ITF2357 10 mg/mL, Placebo, Moxifloxacin Hydrochloride)

      Completed
      • Duchenne and Becker Muscular Dystrophy
      • Polycytemia Vera
      • ITF2357 10 mg/mL
      • +2 more
      • Québec, Canada
        Québec
      Aug 25, 2021

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +46 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 10, 2021

      Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Birmingham, Alabama
      • +151 more
      Aug 22, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +125 more
      • tetanus-CMV fusion peptide vaccine
      • laboratory biomarker analysis
      • Duarte, California
        City of Hope Medical Center
      Feb 28, 2022

      Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Terminated
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +121 more
      Oct 21, 2021

      Periodontitis Chronic Generalized Severe Trial in Beirut (2.5% flurbiprofen, 98% aloe vera, Placebo)

      Completed
      • Periodontitis Chronic Generalized Severe
      • 2.5% flurbiprofen
      • +2 more
      • Beirut, Lebanon
        Beirut Arab University
      Sep 11, 2023

      Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

      Recruiting
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Birmingham, Alabama
      • +155 more
      Aug 12, 2022

      Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

      Recruiting
      • Polycythemia Vera
        • Sohag, Egypt
          Faculty of Medicine
        Aug 12, 2023

        Real World Evidence of Fedratinib Effectiveness in MF

        Not yet recruiting
        • Primary Myelofibrosis
        • +2 more
        • (no location specified)
        May 22, 2023

        Identify and Describe Predictive Factors for Thromboembolic

        Not yet recruiting
        • Polycythemia Vera
        • Hydroxyurea
        • Ruxolitinib
        • (no location specified)
        Nov 2, 2022

        Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

        Recruiting
        • Myelofibrosis
        • +3 more
        • Birmingham, Alabama
        • +148 more
        Oct 10, 2022

        Ruxolitinib in Patients With Myelofibrosis

        Not yet recruiting
        • Myelofibrosis
        • (no location specified)
        Feb 28, 2023

        PTSD, MDD, Anxiety Disorders Trial (TF-CBT)

        Completed
        • Posttraumatic Stress Disorder
        • +2 more
        • TF-CBT
        • (no location specified)
        Aug 23, 2022

        Chronic Pain, Neck Pain Trial in Almería (Monopolar electrical diathermy plus therapeutic yoga, Therapeutic Yoga)

        Recruiting
        • Chronic Pain
        • Neck Pain
        • Monopolar electrical diathermy plus therapeutic yoga
        • Therapeutic Yoga
        • Almería, Almeria, Spain
          Adelaida María Castro Sánchez
        Oct 2, 2023

        Action of Interferon in Treatment of Myeloproliferative

        Recruiting
        • Myeloproliferative Neoplasm
          • Villejuif, Ile De France, France
            Inserm U1287
          Apr 28, 2023

          Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

          Recruiting
          • Myeloproliferative Disorders
          • +4 more
          • La Jolla, California
          • +184 more
          Aug 22, 2022

          Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

          Recruiting
          • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 18, 2022